Anti-Iran Kurdish Official to Asharq Al-Awsat: We Want to Establish Independent State

A woman walks on the street, between banners supporting the referendum for independence of Kurdistan in Erbil, Iraq September 24, 2017. (Reuters)
A woman walks on the street, between banners supporting the referendum for independence of Kurdistan in Erbil, Iraq September 24, 2017. (Reuters)
TT

Anti-Iran Kurdish Official to Asharq Al-Awsat: We Want to Establish Independent State

A woman walks on the street, between banners supporting the referendum for independence of Kurdistan in Erbil, Iraq September 24, 2017. (Reuters)
A woman walks on the street, between banners supporting the referendum for independence of Kurdistan in Erbil, Iraq September 24, 2017. (Reuters)

Vice President of the anti-Iran Kurdistan Freedom Party and commander of the military wing of the party, Hussein Yazdan Bina declared that the fate of any future Kurdish state will be decided by the people through ballot boxes.

He told Asharq Al-Awsat that his party is seeking to follow in the footsteps of Qazi Muhammad, the Kurdish separatist leader who founded the Democratic Party of Iranian Kurdistan and headed the short-lived Republic of Mahabad 73 years ago.

The Kurdistan Freedom Party had, along with the Kurdish Peshmerga forces, waged four years of war against the ISIS terrorist group in Iraq in defense of the Iraqi Kurdistan Region. The party is led by the Muhammad’s oldest son, Ali. It controls the Kurdistan capital Erbil and has tightened its grip over the city after the redeployment of the Iran-backed Popular Mobilization Forces (PMF). The Kurdish authorities in the autonomous have rejected repeated pressure from Tehran to expel the Freedom Party from the region.

Yazdan Bina spoke to Asharq Al-Awsat from Kirkuk city, saying that “Iran has failed in its pressure.”

“The balance of power has changed, as have political equations in the region,” he explained. “It is no longer in a position to dictate demands or exert pressure on the Kurdistan region.”

“The Iranian regime has become exhausted in its search for an exit to its crisis,” he added.

“Iran is unlike any other country in the world. It is a Persian empire that has been built at the expense of other peoples, such as Kurds, Arabs, Balochs and other minorities.”

“The Persians have been hostile to these communities, which are now beginning to reject their rule and are waiting for the right moment to liberate themselves from them,” Yazdan Bina said.

Moreover, he declared that the “empire” has become a major threat to regional and international peace and security.

“Tehran is expanding its hegemony in the region,” he warned. “Should Washington continue its pressure on Tehran and should it bolster its cooperation with the oppressed people, then they can rise up in the near future and liberate themselves.”

“The international community will also be rid of a regime that is the world’s greatest sponsor of terrorism,” he stressed.

Addressing US sanctions against Iran, Yazdan Bina said that they are tailored to ensure Washington’s interests in the region.

“American and western interests coincide with those of the Kurdish people in regards to combating global terrorism, cementing democracy in the region and weakening the Tehran regime,” he went on to say.

He noted that the American administration's declaration that it does not seek regime change in Iran has not really helped Tehran maintain its stability. He instead predicted that the regime will collapse “soon.”

“The regime’s reckless disregard of the sovereignty of regional countries and its arrogance may lead to a wide-scale war in the area. This may ultimately lead the US or even Israel to resort to military force because Iran is a great threat to Israel,” Yazdan Bina warned.

Asked if the Freedom Party would take part in any American military strike against Iran, he replied that the regime left the Kurds with no choice but to take up arms to fight for their legitimate rights.

Iran is the Kurds and democracy’s greatest enemy, he declared.

The party will support any political, military or economic effort aimed at overthrowing the regime, he vowed.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.